REDMOND, Wash.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company will present new data on EGS’ Transoral Incisionless Fundoplication (TIF®) procedure at the Digestive Disease Week (DDW) 2016 annual meeting. The meeting is taking place from May 21 – 24, 2016 at the San Diego Convention Center in San Diego, California.
